...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Daru Journal of pharmaceutical sciences. >Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
【24h】

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries

机译：伊朗制药市场趋势分析; 1997–2010;对发展中国家的政策影响

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background So far, no detailed study of the Iranian pharmaceutical market has been conducted, and only a few studies have analyzed medicine consumption and expenditure in Iran. Pharmaceutical market trend analysis remains one of the most useful instruments to evaluate the pharmaceutical systems efficiency. An increase in imports of medicines, and a simultaneous decrease in domestic production prompted us to investigate the pharmaceutical expenditure structure. On the other hand, analyzing statistics provides a suitable method to assess the outcomes of national pharmaceutical policies and regulations. Methods This is a descriptive and cross-sectional study which investigates the Iranian pharmaceutical market over a 13-year period (1997–2010). This study used the Iranian pharmaceutical statistical datasheet published by the Iranian Ministry of Health. Systematic searches of the relevant Persian and English research literature were made. In addition, official government documents were analyzed as sources of both data and detailed statements of policy. Results Analysis of the Iranian pharmaceutical market in the 13-year period shows that medicine consumption sales value growth has been 28.38% annually. Determination of domestic production and import reveals that 9.3% and 42.3% annual growth, respectively, have been experienced. Conclusions The Iranian pharmaceutical market has undergone great growth in comparison with developing countries and the pharmerging group, and the market is expanding quickly while a major share goes to biotechnology drugs, which implies the need to commercialization activities in novel fields like pharmaceutical biotechnology. This market expansion has been in favor of imported medicine in sales terms, caused by the reinforcement of suspicious policies of policy makers that necessitates fundamental rearrangements.
机译：背景技术迄今为止，尚未对伊朗药品市场进行详细研究，只有很少的研究分析了伊朗的药品消费和支出。制药市场趋势分析仍然是评估制药系统效率的最有用工具之一。药品进口的增加和国内生产的同时下降促使我们研究药品支出结构。另一方面，分析统计数据为评估国家药品政策和法规的结果提供了一种合适的方法。方法这是一项描述性和横断面研究，调查了13年期间（1997-2010年）的伊朗制药市场。这项研究使用了伊朗卫生部发布的伊朗制药统计数据表。系统搜索了相关的波斯和英语研究文献。此外，对官方政府文件进行了分析，作为数据和详细政策声明的来源。结果过去13年中伊朗药品市场的分析表明，药品消费销售价值每年增长28.38％。对国内生产和进口的确定表明，分别经历了9.3％和42.3％的年增长率。结论与发展中国家和制药集团相比，伊朗制药市场经历了巨大的增长，并且市场正在迅速扩展，而生物技术药物则占有主要份额，这意味着需要在诸如药物生物技术等新领域进行商业化活动。由于决策者的可疑政策的加强，必须进行根本性的重新安排，这种市场扩展在销售方面一直有利于进口药品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号